Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00168480 · ClinicalTrials.gov registry record · Phase 4
A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis
A Phase 4 study, sponsored by Allergan.
- Completed
- Registry status
- Phase 4
- Development phase
- 424
- Enrollment target
NCT00168480: Completed Phase 4 study, sponsored by Allergan.
NCT00168480 is a Phase 4 study that has completed, run by Allergan. The registered enrollment target is 424 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (18% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00168480, a Phase 4 study, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 424 participants
- Enrollment target
Study Summary
This is a three year open-label study in subjects with axillary hyperhidrosis.
Interventions
- BIOLOGICAL Botulinum Toxin Type A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 424 participants |
| Start Date | 2003-11 |
| Est. Completion | 2007-04 |
| Phase | Phase 4 |
What the finished NCT00168480 record still lists
NCT00168480 is an interventional study that assigns participants to a tested intervention. The registered 424 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (18% lower).
The record links to 0 conditions, and to 1 intervention - of which Botulinum Toxin Type A is the first listed.
NCT00168480 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00168480 about?
NCT00168480 is a clinical study titled "A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis". This is a three year open-label study in subjects with axillary hyperhidrosis.
What is the current status of trial NCT00168480?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 424 participants. The study started on 2003-11. Estimated completion is 2007-04.
What interventions are being tested in trial NCT00168480?
The interventions under investigation include: Botulinum Toxin Type A (BIOLOGICAL).
Who is sponsoring clinical trial NCT00168480?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00168480's enrollment target sits among peer trials
424 199th of 2000 higher than 1,801 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05632770 · 424 participants · NA
A Deployment Focused Pragmatic Trial of Optimal Stepped Care Intervention Targeting PTSD and Comorbidity for Acutely Hospitalized Injury Survivors Treated in US Trauma Care Systems
- NCT05733767 · 424 participants · Phase 2
Smoking Cessation Pharmacotherapy-Nurse Practitioner Led Tobacco Treatment Team Study
- NCT06978127 · 424 participants · NA
Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients
- NCT07140913 · 424 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia